Search results
Results from the WOW.Com Content Network
Cognitive dysfunction syndrome in dogs is an established diagnosis, but there has been limited research for cats and treatment options are limited. [13] Drugs used for treatment of the disease have been approved for use in dogs. However, they are used off-label in treatment of cats. [1] Early diagnosis improves results of long-term treatment. [6]
The role of cytokines in sundowning can improve our understanding of the pathology. [12] Injection of chemogenetic ligands into the eye to stimulate the SCN through the retinohypothalamic tract is another possible treatment for sundown syndrome as a similar strategy has been thought to have potential with regards to therapy for mood-related ...
Also known as “sundowner’s syndrome,” sundowning is a set of symptoms or behaviors that can be seen in some people with Alzheimer’s disease and dementia, according to the Alzheimer’s ...
Around 9–12 months, or when the cat reaches maturity. Duration: The syndrome will remain present for the cat's entire life, but episodes only last for one to two minutes. Treatment: Behavioural adaptation, pharmaceuticals and alternative medicine. Prognosis: Good, provided the cat doesn't self-mutilate excessively.
For premium support please call: 800-290-4726 more ways to reach us
Avian influenza in cats; Bladder cancer in cats and dogs; Bone cancer in cats and dogs; Cancer in cats; Cat worm infections; Cat flu, an upper respiratory tract infection, caused by: Bordetella bronchiseptica [3] Chlamydophila felis; Feline calicivirus [4] Feline viral rhinotracheitis (FVR) [4] FHV-1 [4] Cat-scratch disease; Cat skin disorders
The prognosis is poor and supportive treatment is necessary. Recovery in cats may take up to one year. [10] Giant axonal neuropathy is a rare disease in the German Shepherd dog. It usually becomes evident between the ages of 14 and 16 months. [1] Symptoms include rear limb weakness, decreased reflexes, muscle atrophy, megaesophagus, and loss of ...
Maropitant (INN; [3] brand name: Cerenia, used as maropitant citrate , is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs [4] [5] and in 2012, for cats. [6]